Related references
Note: Only part of the references are listed.National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2008)
CSF levels of growth factors and plasminogen activators in leptomeningeal metastases
B. van de Langerijt et al.
NEUROLOGY (2006)
CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases
JC Reijneveld et al.
NEUROLOGY (2005)
Leptomeningeal metastases from solid malignancy: a review
S Taillibert et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
被撤回的出版物: Neoplastic meningitis (Retracted article. See vol. 28, pg 4018, 2010)
MC Chamberlain
JOURNAL OF CLINICAL ONCOLOGY (2005)
Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer
C Kosmas et al.
MEDICAL ONCOLOGY (2005)
Intrathecal production and secretion of vascular endothelial growth factor during cryptococcal meningitis
FEJ Coenjaerts et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Lesson of the week - Hypothyroidism mimicking intra-abdominal malignancy
STM Krishnan et al.
BRITISH MEDICAL JOURNAL (2002)
Vascular endothelial growth factor in bacterial meningitis: Detection in cerebrospinal fluid and localization in postmortem brain
M van der Flier et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Share Paper
